BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 22067317)

  • 1. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
    Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
    Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
    Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
    Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
    Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
    Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
    Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
    Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
    J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
    Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
    Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
    Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
    Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
    Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
    Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 gene therapy as treatment for obesity and insulin resistance.
    Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
    Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
    Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.
    Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1197-204. PubMed ID: 19738035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF21 promotes metabolic homeostasis via white adipose and leptin in mice.
    Véniant MM; Hale C; Helmering J; Chen MM; Stanislaus S; Busby J; Vonderfecht S; Xu J; Lloyd DJ
    PLoS One; 2012; 7(7):e40164. PubMed ID: 22792234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.